People aged 16 and over who receive blood tests in A&E at Leeds General Infirmary and St James's University Hospital are now ...
Goldman Sachs downgraded Dynavax Technologies Corporation (NASDAQ:DVAX) reflecting updated views and recent competitive ...
Vietnam Investment Review on MSN3d
Lion TCR's Liocyx-M004 Receives FDA Clearance to Launch Global Multicenter Phase 2 Clinical Trial in HBV-Related Hepatocellular CarcinomaLion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance from ...
Just a few months after Vir Biotechnology lost an emergency authorization for its COVID-19 antibody, Marianne de Backer ...
Revisiting the Natural History of Chronic Hepatitis B: Impact of New Concepts on Clinical Management
even in the low viremic phase. Hepatitis B e antigen seroconversion with hepatitis B virus (HBV) DNA levels just below 10 5 copies/mL may not be an adequate treatment endpoint for Asian CHB patients.
As many as 140,000 bereaved parents, children and siblings of infected blood scandal victims may claim compensation under new ...
Proceeds expected to fund the start of the ALG-000184 Phase 2 clinical studyFunding expected to extend cash runway into the second half of ...
NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback